Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (30,041)
  • Open Access

    LEGENDS IN UROLOGY

    LEGENDS IN UROLOGY

    Julio E. Pow-Sang

    Canadian Journal of Urology, Vol.21, No.1, pp. 7092-7093, 2014

    Abstract This article has no abstract. More >

  • Open Access

    EDITORIAL

    Prostate Cancer Genomics: Understanding the New Landscape

    Leonard G. Gomella

    Canadian Journal of Urology, Vol.21, No.1, pp. 7091-7091, 2014

    Abstract This article has no abstract. More >

  • Open Access

    HOW I DO IT

    How I do it: prostate cryoablation (PCry)

    Rodrigo Donalisio da Silva, Paulo Jaworski, Diedra Gustafson, Leticia Nogueira, Wilson Molina, Fernando J. Kim

    Canadian Journal of Urology, Vol.21, No.2, pp. 7251-7254, 2014

    Abstract Prostate cryoablation (PCry) is a well-established minimally invasive therapy for the treatment of prostate cancer. Unfortunately, PCry still carries the stigma of a high rate recto-urethral fistula procedure but with the advent of argon/helium gas technology, urethral warmer and high quality transrectal ultrasound imaging, complications decreased and efficacy increased. The Denver Health Medical Center’s technique in prostate cryoablation is described as follows. More >

  • Open Access

    RESIDENT’S CORNER

    Radiographical resolution of renal lymphangiomatosis following cardiac transplantation

    Rick C. Slater, Uzoma Iheagwara, Mang L. Chen

    Canadian Journal of Urology, Vol.21, No.2, pp. 7248-7250, 2014

    Abstract Renal lymphangiomatosis is a disease characterized by abnormal formation of perirenal lymphatic vessels that fail to communicate with other retroperitoneal lymphatics; as a result, perirenal lymphatics dilate and form cysts. While typically an asymptomatic incidental finding, renal lymphangiomatosis rarely presents as flank or abdominal pain, ascites, impaired renal function, hypertension, hematuria, or proteinuria. Here we present the first known case of renal lymphangiomatosis found to spontaneously resolve following cardiac transplantation. More >

  • Open Access

    RESIDENT’S CORNER

    Novel management approach to connecting tube erosion of artificial urinary sphincter

    Akwasi A. Boateng, Mahmoud A. Mohamed, Ayman E. Mahdy

    Canadian Journal of Urology, Vol.21, No.2, pp. 7246-7247, 2014

    Abstract Artificial urinary sphincter (AUS) erosion often involve the urethral cuff and is managed by complete or partial device removal. Abdominal wall erosion of AUS tubing has not been previously reported and its management is unknown. We report tube erosion (TE) of AUS successfully managed without device explant. An 81-year-old male with AUS for post-prostatectomy incontinence presented with TE at the site of inguinal incision without signs or symptoms of infection. The exposed tube was reduced and wound was closed after copious antibiotic solution irrigation. No complications were noted at 2 month follow up. AUS-TE can More >

  • Open Access

    PEDIATRIC UROLOGY

    Distal hypospadias repair using only glans wing mobilization and approximation

    John M. Lacy1, Lauren N. Hendrix1, Campbell Grant2, Ali M. Ziada1

    Canadian Journal of Urology, Vol.21, No.2, pp. 7241-7245, 2014

    Abstract Introduction: Since its first description in 1994, tubularized incised plate (TIP) technique has become the most commonly performed hypospadias procedure and involves incision of the urethral plate with subsequent tubularization. Glans wings are then developed to cover the neourethra, thereby creating a cosmetically appealing repair. In some distal hypospadias cases, mobilization and approximation of glans wings is sufficient to create a normal appearing urethral meatus.
    Materials and methods: A retrospective chart review of all pediatric urology patients who underwent hypospadias repair by a single surgeon at the University of Kentucky between July 1, 2010 and April… More >

  • Open Access

    ARTICLE

    Vasectomy as a reversible form of contraception for select patients

    Mary K. Samplaski1, Ariande Daniel2, Keith Jarvi1,2,3

    Canadian Journal of Urology, Vol.21, No.2, pp. 7234-7240, 2014

    Abstract Introduction: To provide an effective form of birth control, men may choose a reversible or permanent form of contraception. Vasectomy is presently offered as a permanent option for male contraception. We have had patients who were interested in vasectomy and reversal as a temporary birth control option. The purpose of this paper is to determine if vasectomy should be offered for selected couples as a temporary form of contraception and under which circumstances.
    Materials and methods: A literature review was conducted to determine the available reversible contraceptive options, risks, failure rates and contraindications to each, and… More >

  • Open Access

    ARTICLE

    The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy

    Josep M. Gaya1,2, Justin Matulay1, Gina M. Badalato1, Dara D. Holder1, Gregory Hruby1, James McKiernan1

    Canadian Journal of Urology, Vol.21, No.2, pp. 7228-7233, 2014

    Abstract Introduction: Involvement of the prostatic urethra by bladder cancer directly impacts prognosis, risk of urethral recurrence, and timing of radical cystectomy (RC); it also affects the type of urinary diversion chosen. Both cold cup biopsies and transurethral (TUR) loop biopsies have been used to evaluate the status of the prostatic urethra. We report our 20 year experience with preoperative and intraoperative prostatic urethral biopsies to determine relative efficacy and associated treatment implications.
    Materials and methods: The Columbia University urologic oncology database was reviewed and yielded 234 men who underwent preoperative endoscopic biopsies of the prostatic urethra… More >

  • Open Access

    ARTICLE

    Multi-institutional outcomes and cost effectiveness of using alvimopan to lower gastrointestinal morbidity after cystectomy and urinary diversion

    Anup Vora, Daniel Marchalik, Hanaa Nissim, Keith Kowalczyk, Gaurav Bandi, Kevin McGeagh, John Lynch, Krishnan Venkatesan, Reza Ghasemian, Jonathan Hwang, Mohan Verghese

    Canadian Journal of Urology, Vol.21, No.2, pp. 7222-7227, 2014

    Abstract Introduction: Radical cystectomy is associated with significant morbidity and cost, with rates of gastrointestinal complications as high as 30%. Alvimopan is a mu opioid receptor antagonist that has been shown in randomized-control trials to accelerate gastrointestinal recovery in patients undergoing bowel resection with primary anastamosis. We report our experience with gastrointestinal recovery for patients undergoing cystectomy with urinary diversion treated with alvimopan and cost benefit associated.
    Materials and methods: Between January 2008 and October 2012, 80 patients underwent radical cystectomy with urinary diversion at two institutions. Forty-two patients in our study did not receive alvimopan preoperatively.… More >

  • Open Access

    ARTICLE

    Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia

    Bilal Chughtai1, Claire Dunphy1, Richard Lee1, Daniel Lee1, Seema Sheth1, Leonard Marks2, Steven A. Kaplan1, Alexis E. Te1

    Canadian Journal of Urology, Vol.21, No.2, pp. 7217-7221, 2014

    Abstract Introduction: We assessed the efficacy of onabotulinumtoxinA (Botox, Allergan Inc., Irvine, CA, USA) in patients with refractory overactive bladder (OAB) after treatment for benign prostatic hyperplasia (BPH).
    Materials and methods: This was a two-center, randomized, double-blinded pilot study conducted in patients with OAB secondary to bladder outlet obstruction (BOO), refractory to anticholinergic medication and persistent for greater than 3 months after surgical intervention to relieve obstruction, with an International Prostate Symptom Score (IPSS) >12. Patients were randomized in 1:1 fashion to either 200 units of onabotulinumtoxinA versus placebo. Fifteen patients received onabotulinumtoxinA versus 13 who received… More >

Displaying 24291-24300 on page 2430 of 30041. Per Page